上(shàng)海麥克林生(shēng)化(huà)科技有限公司是一(yī)家高端研發用試劑産品的制造商(shāng)與供應商(shāng),旨在為(wèi)全球科技事(shì)業和工業領域客戶提供系統的産品資源及配套技術服務(wù)。
麥克林成立于2013年,公司總部設在上(shàng)海浦東新(xīn)區張江高科技園區,在美國加州、北京、廣州、成都、武漢、鄭州等主要城市(shì)設立有分(fēn)公司和辦事(shì)處,可為(wèi)全球客戶提供便捷全方位的服務(wù)。
麥克林事(shì)業朝氣蓬勃,在上(shàng)海化(huà)工園區設有20000平方米的生(shēng)産研發基地和龐大的倉儲物流中心,憑着一(yī)支富有創造天賦的專業團隊,新(xīn)技術、新(xīn)産品層出不窮。 目前,麥克林産品已達30000 多種,并呈持續增長态勢。産品包括通用試劑、藥物合成試劑、手性化(huà)合物、催化(huà)劑及配體(tǐ)、分(fēn)析試劑、生(shēng)物試劑等。麥克林的柔性生(shēng)産線能(néng)夠快(kuài)速提供小批量、多品種的産品,可以滿足實驗室研發、中試乃至規模化(huà)生(shēng)産需要。
麥克林秉承“商(shāng)德唯信、利末義本”的經營理(lǐ)念,緻力于與化(huà)學、醫(yī)藥、分(fēn)析、食品、能(néng)源、材料等領域的客戶建立互信、長久的合作(zuò)關(guān)系,為(wèi)實現(xiàn)“服務(wù)于全球的科技現(xiàn)代化(huà),為(wèi)人(rén)類科技事(shì)業繁榮提供營養品及催化(huà)劑”的使命而不懈努力!
貨号 | 項目中文名稱 | 項目英文名稱 | 項目規格 | 包裝規格 | 牌價 | 銷售價格 | CAS号 | 分(fēn)子(zǐ)式 | 分(fēn)子(zǐ)量 |
---|---|---|---|---|---|---|---|---|---|
R854234-100mg | (R)-3,3'-雙[3,5-二(三氟甲基)苯基]-5,5',6,6',7,7',8,8'-八氫-1,1'-聯萘酚膦酸酯 | (11bR)-2,6-Bis[3,5-bis(trifluoromethyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin | ≥98%,99%e.e. | 100mg | 3170 | 2536 | 1011465-24-9 | C36H25F12O4P | 780.5 |
R854235-100mg | (R)-3,3'-雙(2-萘基)-5,5',6,6',7,7',8,8'-八氫-1,1'-聯萘酚膦酸酯 | (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-2-naphthalenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin | ≥98%,99%e.e. | 100mg | 3170 | 2536 | 922711-75-9 | C40H33O4P | 608.7 |
R854236-100mg | (R)-3,3'-雙(1-萘基)-5,5',6,6',7,7',8,8'-八氫-1,1'-聯萘酚膦酸酯 | (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-1-naphthalenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin | ≥95%,99%e.e. | 100mg | 3197 | 2557.6 | 1242066-20-1 | C40H33O4P | 608.7 |
R854237-100mg | (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin | (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin | ≥98%,99%e.e. | 100mg | 5215 | 4172 | 929294-27-9 | C50H65O4P | 761 |
S854238-100mg | (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin | (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin | ≥98%,99%e.e. | 100mg | 5215 | 4172 | 878111-20-7 | C50H65O4P | 761 |
R854239-100mg | (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-9-phenanthrenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin | (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-9-phenanthrenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin | ≥98%,99%e.e. | 100mg | 5130 | 4104 | 934201-93-1 | C48H37O4P | 708.8 |
S854240-100mg | (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-9-phenanthrenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin | (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-di-9-phenanthrenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin | ≥98%,99%e.e. | 100mg | 5130 | 4104 | 1028416-47-8 | C48H37O4P | 708.8 |
R854241-100mg | (11bR)-2,6-Di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin | (11bR)-2,6-Di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin | ≥95%,99%e.e. | 100mg | 5062 | 4049.6 | 1011465-29-4 | C48H37O4P | 708.8 |
R854242-100mg | (11bR)-2,6-Bis(4-chlorophenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin | (11bR)-2,6-Bis(4-chlorophenyl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin | ≥98%,99%e.e. | 100mg | 2936 | 2348.8 | 915038-16-3 | C32H27Cl2O4P | 577.4 |
R854243-100mg | (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-diphenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin | (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-diphenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin | ≥98%,99%e.e. | 100mg | 2733 | 2186.4 | 791616-65-4 | C32H29O4P | 508.5 |